Terms ending in 2027
Every in-force patent on Gilead Sciences, Inc.'s record whose computed term ends in 2027, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 7,956,179 | Process for Preparing an A2A-ADENOSINE Receptor Agonist and Its Polymorphs In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 8,106,183 | Process for Preparing an A2A-ADENOSINE Receptor Agonist and Its Polymorphs In force · Medium confidence | Gilead Sciences, Inc. | In force | Medium confidence | |
| US 8,268,988 | Process for Preparing an A2A-ADENOSINE Receptor Agonist and Its Polymorphs In force · Medium confidence | Gilead Sciences, Inc. | In force | Medium confidence | |
| US 8,524,883 | Monohydrate of (1-{9-[(4S,2R,3R,5R)-3,4-Dihydroxy-5-(HYDROXYMETHYL)OXOLAN-2-YL]-6-Aminopurin-2-YL}PYRAZOL-4-YL)-N-METHYLCARBOXAMIDE In force · Medium confidence | Gilead Sciences, Inc. | In force | Medium confidence | |
| US RE47,301 | Process for Preparing an A2A-ADENOSINE Receptor Agonist and Its Polymorphs In force · Low confidence | Gilead Sciences, Inc. | In force | Low confidence | |
| US 8,431,745 | Process for Preparation of HIV Protease Inhbitors In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 7,671,192 | Process for Preparing an A2A-ADENOSINE Receptor Agonist and Its Polymorphs In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 8,609,671 | Method of inhibiting hepatic fibrosis as a result of liver replacement or repair using A2B adenosine receptor antagonists In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 8,188,099 | Method of Decreasing Hepatotoxic Side Effects Using A2B Adenosine Receptor Antagonists In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 8,435,969 | Method and Compositions for Treating Hematological Malignancies In force · High confidence | Vetdc IP, LLC | In force | High confidence | |
| 18 more term ends in 2027 · Pro | |||||
10 of 28 patents shown. Soonest term end first, then patent number.
Pro members see all 28, all of them expiring within the 18 months from Nov 17, 2026.
25 of these are in force and held by Gilead Sciences, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.